Literature DB >> 23931783

Examination and clinical care of the patient with neuropathy.

Gérard Said1.   

Abstract

Examination of a patient with peripheral neuropathy starts with careful questioning of the patient about the history of symptoms and signs and of a possible familial disorder. Several steps are required during examination of the patient with peripheral neuropathy: first the pattern of neuropathy and site of lesions should be determined: roots, nerve trunks, focal, multifocal, length-dependent generalized polyneuropathy, the type of nerve fibers predominantly affected, the association with trophic changes and autonomic dysfunction, the course of the disease ranging from acute inflammatory polyneuritis or fulminant multifocal neuropathy to an extremely slow progression as in Charcot-Marie-Tooth syndromes. At the end of this first contact with the patient, the neurologist must decide which investigations seem necessary and their timing including electrophysiological tests, imaging, CSF examination, blood tests, nerve and muscle biopsy, DNA testing, etc. In some cases, life-threatening manifestations, including weakness of respiratory muscles or swallowing difficulty, or autonomic dysfunction, require urgent therapeutic decisions.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  cramps; fasciculations; fibrillations; focal neuropathy; length-dependent neuropathy; multifocal neuropathy; myokymia; nerve biopsy; osteoarthropathy; plantar ulcers; tendon reflexes

Mesh:

Year:  2013        PMID: 23931783     DOI: 10.1016/B978-0-444-52902-2.00013-8

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  2 in total

Review 1.  Peripheral neuropathy in persons with tuberculosis.

Authors:  Arnold T Mafukidze; Marianne Calnan; Jennifer Furin
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2015-12-03

2.  M1 macrophage infiltration exacerbate muscle/bone atrophy after peripheral nerve injury.

Authors:  Nobuhiro Shimada; Asuka Sakata; Takashi Igarashi; Mamoru Takeuchi; Satoshi Nishimura
Journal:  BMC Musculoskelet Disord       Date:  2020-01-20       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.